Chartsbank is a comprehensive database containing information on more than 3000 new drugs in development, inclusive of pre-clinical research up to phase IV development

Subscribers view details.


 
Please Select Filter Criteria for the drug pipeline
Drug Pipeline by drug name:
Drug Pipeline by Company:
Drug Pipeline by Disease:

Subscribe

Drug Pipeline by Generic :
Drug Pipeline by Current Status:
Drug Pipeline by ICN:

...121122123124125126127128129130...
CompanyDrug NameStatusIndication Group
AETERNA ZENTARIS No drug name in Phase IIAntineoplastic & immunomodulating agents
Coley Pharmaceutical Group No drug name in Phase IIIAntineoplastic & immunomodulating agents
EntreMed No drug name in Phase IIAntineoplastic & immunomodulating agents
GPC Biotech No drug name in Phase IIAntineoplastic & immunomodulating agents
Novartis No drug name in Phase IIAntineoplastic & immunomodulating agents
OncoGenex Technologies No drug name accomplished Phase IAntineoplastic & immunomodulating agents
Wyeth No drug name in Phase IIAntineoplastic & immunomodulating agents
Transgene No drug name in Phase IIAntineoplastic & immunomodulating agents
Wyeth No drug name in Phase IIAntineoplastic & immunomodulating agents
Bayer No drug name in Phase IIAntineoplastic & immunomodulating agents
Valentis No drug name in Phase IIAntineoplastic & immunomodulating agents
Northwest Biotherapeutics No drug name in Phase IAntineoplastic & immunomodulating agents
Biovitrum No drug name in Phase IIAlimentary tract & metabolism
Genaera No drug name in Phase IAlimentary tract & metabolism
GlaxoSmithKline No drug name in Phase IAlimentary tract & metabolism
GlaxoSmithKline No drug name in Phase IIAlimentary tract & metabolism
Manhattan No drug name accomplished Phase IIAlimentary tract & metabolism
Merck No drug name in Phase IIAlimentary tract & metabolism
Merck No drug name in Phase IIAlimentary tract & metabolism
Merck No drug name in Phase IIAlimentary tract & metabolism
...121122123124125126127128129130...




Drug Pipeline Copyright © 2005- 2017 All Rights Reserved.